Bank of New York Mellon
PRVA icon

Bank of New York Mellon’s Privia Health PRVA Stock Holding History

Bank of New York Mellon’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.4M Sell
2,892,536
-50,957
-2% -$1.18M 0.01% 828
2026
Q1 		$60.5M Sell
2,943,493
-102,023
-3% -$2.3M 0.01% 883
2025
Q4 		$72.2M Sell
3,045,516
-27,965
-0.9% -$681K 0.01% 803
2025
Q3 		$76.5M Buy
3,073,481
+920,923
+43% +$19.8M 0.01% 775
2025
Q2 		$49.5M Sell
2,152,558
-58,646
-3% -$1.36M 0.01% 1005
2025
Q1 		$49.6M Sell
2,211,204
-148,646
-6% -$3.45M 0.01% 972
2024
Q4 		$46.1M Sell
2,359,850
-227,357
-9% -$4.51M 0.01% 1074
2024
Q3 		$47.1M Sell
2,587,207
-293,566
-10% -$5.6M 0.01% 1078
2024
Q2 		$50.1M Sell
2,880,773
-594,571
-17% -$10.5M 0.01% 1033
2024
Q1 		$68.1M Sell
3,475,344
-258,500
-7% -$5.46M 0.01% 867
2023
Q4 		$86M Sell
3,733,844
-306,183
-8% -$6.85M 0.02% 722
2023
Q3 		$92.9M Buy
4,040,027
+62,543
+2% +$1.59M 0.02% 636
2023
Q2 		$104M Buy
3,977,484
+408,843
+11% +$10.8M 0.02% 608
2023
Q1 		$98.5M Sell
3,568,641
-46,910
-1% -$1.24M 0.02% 625
2022
Q4 		$82.1M Sell
3,615,551
-37,983
-1% -$1.06M 0.02% 699
2022
Q3 		$124M Sell
3,653,534
-361,606
-9% -$13.4M 0.03% 509
2022
Q2 		$117M Sell
4,015,140
-122,940
-3% -$3.13M 0.03% 553
2022
Q1 		$111M Buy
4,138,080
+1,052,856
+34% +$24.9M 0.02% 626
2021
Q4 		$79.8M Buy
3,085,224
+1,220,740
+65% +$30.4M 0.01% 833
2021
Q3 		$43.9M Buy
1,864,484
+739,298
+66% +$25.8M 0.01% 1220
2021
Q2 		$49.9M Buy
+1,125,186
New +$41.5M 0.01% 1139

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bank of New York Mellon's PRVA Position: Q2 2026 in Review

Bank of New York Mellon reduced its Privia Health (PRVA) stake by 1.7% in Q2 2026, selling an estimated $1.18M and leaving 2,892,536 shares worth $74.4M. The position accounts for 0.01% of the portfolio, ranked #828.

Bank of New York Mellon first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $124M in Q3 2022. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Bank of New York Mellon held 2,892,536 shares of Privia Health worth $74.4M as of Q2 2026.
  • Bank of New York Mellon sold 50,957 Privia Health shares in Q2 2026, an estimated $1.18M.
  • Privia Health made up 0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #828 holding.
  • Bank of New York Mellon first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Privia Health position peaked at $124M in Q3 2022.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.